Link to this page
Ontology of Drug Neuropathy Adverse Events
Preferred Name | zafirlukast | |
Synonyms |
zafirlukast InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35) COc1cc(ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12)C(=O)NS(=O)(=O)c1ccccc1C 4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide InChIKey=YEEZWCHGZNKEEK-UHFFFAOYSA-N C31H33N3O6S Accolate cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate |
|
Definitions |
An indole that has formula C31H33N3O6S. |
|
ID |
http://purl.obolibrary.org/obo/CHEBI_10100 |
|
database_cross_reference |
KEGG COMPOUND:107753-78-6 KEGG COMPOUND:C07206 Beilstein:3641829 Wikipedia:Zafirlukast KEGG DRUG:D00411 ChemIDplus:107753-78-6 DrugBank:DB00549
|
|
definition |
An indole that has formula C31H33N3O6S.
|
|
has_exact_synonym |
cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate
|
|
has_related_synonym |
zafirlukast InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35) COc1cc(ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12)C(=O)NS(=O)(=O)c1ccccc1C 4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide InChIKey=YEEZWCHGZNKEEK-UHFFFAOYSA-N C31H33N3O6S Accolate cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate
|
|
has_RxCUI |
114970
|
|
id |
CHEBI:10100
|
|
imported from | ||
label |
zafirlukast
|
|
notation |
CHEBI:10100
|
|
prefLabel |
zafirlukast
|
|
subClassOf |
http://purl.obolibrary.org/obo/CHEBI_35358 |
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |